Evidence map›Paper›PMID 41326693›Full record

ArticleThe EMBO journal2026

Lenacapavir-induced capsid damage uncovers HIV-1 genomes emanating from nuclear speckles.

Thorsten G Müller, Severina Klaus, Vojtech Zila, Bojana Lucic, Carlotta Penzo, Svenja L Nopper, Gonen Golani, Maria Anders-Össwein, Vera Sonntag-Buck, Anke-Mareil Heuser and 5 more

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Thorsten G MüllerDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany. muellert@ie-freiburg.mpg.de.ORCID http://orcid.org/0000-0002-4197-6224
Severina KlausDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany.
Vojtech ZilaDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany.ORCID http://orcid.org/0000-0003-2032-3600
Bojana LucicDepartment of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, 69120, Germany.
Carlotta PenzoDepartment of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, 69120, Germany.
Svenja L NopperDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany.
Gonen GolaniInstitute for Theoretical Physics, Heidelberg University, Heidelberg, 69120, Germany.ORCID http://orcid.org/0000-0003-4792-6807
Maria Anders-ÖssweinDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany.
Vera Sonntag-BuckDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany.
Anke-Mareil HeuserDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany.
Ulrich S SchwarzInstitute for Theoretical Physics, Heidelberg University, Heidelberg, 69120, Germany.ORCID http://orcid.org/0000-0003-1483-640X
Vibor LaketaDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany.
Marina LusicDepartment of Infectious Diseases, Integrative Virology, Heidelberg University, Heidelberg, 69120, Germany.ORCID http://orcid.org/0000-0002-0120-3569
Barbara MüllerDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany.ORCID http://orcid.org/0000-0001-5726-5585
Hans-Georg KräusslichDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, 69120, Germany. Hans-Georg.Kraeusslich@med.uni-heidelberg.de.ORCID http://orcid.org/0000-0002-8756-329X

Funding

Deutsche Forschungsgemeinschaft (DFG) 240245660Deutsches Zentrum für Infektionsforschung (DZIF) TTU HIV
6 · The paper itself

Abstract

Following cell entry, HIV-1 capsids enter the nucleus by passage through nuclear pores and reach nuclear speckles with subsequent uncoating of the reverse-transcribed genome and its integration into speckle-associated chromatin domains. Here, we characterized the ultrastructure of HIV-1 subviral complexes in nuclei of primary monocyte-derived macrophages and cell lines using live-cell imaging, super-resolution microscopy, and correlative light and electron tomography in the absence and presence of capsid-targeting inhibitors Lenacapavir and PF74. Capsid-like structures containing viral DNA, as well as broken capsids, clustered in nuclear speckles and were displaced from speckles by drug treatment. This was accompanied by alteration of the nuclear capsid structure, with electron-dense protrusions emanating from the narrow end of capsid cones and exposure of integration-competent genomic HIV-1 DNA. Our data indicate that synthesis of genomic dsDNA can be completed inside the closed HIV-1 capsid, and speckle-associated factors could regulate genome uncoating. This may ensure that genome uncoating occurs at optimal sites for integration into transcriptionally active chromatin. The results also shed further light on the mechanism of action of Lenacapavir.

Indexed as

Anti-HIV AgentsCapsidCell NucleusGenome, ViralHIV-1AcetamidesDNA, ViralHIV InfectionsHumansIndazolesMacrophagesVirus IntegrationVirus UncoatingAcetamidesAnti-HIV AgentsDNA, ViralIndazoleslenacapavirHIV, CapsidLenacapavirNuclear SpecklesReverse TranscriptionUncoating

Identifiers

PMID41326693
PMCPMC12811339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.